Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar
FDA Forms Office of Combination Products;
Obituary: Ellen Tobin, Consultant, Championed Patients’ Needs;
Report on Carcinogens Lists Estrogen, UV Light, Wood Dust;
Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;
Funding Opportunities
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- FDA’s OCE publishes three final guidances to increase clinical trial enrollment









